glp-1 analogues examples Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1-based therapies: current knowledge of

p=0.004), a finding corroborated by the SUSTAIN-6 trial

Animal studies have documented potential developmental effects at high doses, which led the FDA to assign a Category C classificationa label indicating caution rather than proven danger in humans

doi: 10.1038/s41574-019-0176-8 22

Although the findings are not always consistent, changes in the brainstem have been very common, especially structural changes, mainly a decrease in grey or white matter volume in patients, often pronounced in relation to the symptom burden of fatigue, pain and autonomic symptoms

It consists of a 31-amino acid peptide backbone with several structural modifications designed to extend its biological half-life, including a C-18 fatty acid chain attached via a linker to a lysine residue